Pharmacists Expand Access to Reproductive heaLthcare

Last updated: April 2, 2024
Sponsor: Oregon Health and Science University
Overall Status: Completed

Phase

N/A

Condition

Contraception

Treatment

Clinician prescription

Pharmacist prescription

Clinical Study ID

NCT03830567
OHSU IRB 16158
  • Ages 18-51
  • Female
  • Accepts Healthy Volunteers

Study Summary

Prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates, as well as measures of safety and acceptability.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Women presenting to initiate hormonal contraception at a study pharmacy

Exclusion

Exclusion Criteria:

  • Pregnancy
  • Contraindications to hormonal contraception
  • Under 18 years of age
  • Unable or unwilling to consent

Study Design

Total Participants: 471
Treatment Group(s): 2
Primary Treatment: Clinician prescription
Phase:
Study Start date:
January 27, 2019
Estimated Completion Date:
February 28, 2022

Study Description

Direct prescription of hormonal contraception (HC) by pharmacists, without a doctor's visit or medical prescription, is a strategy to improve access to contraception and reduce unintended pregnancy. Oregon is the first state in the nation to implement legislation, as of January 1, 2016, expanding the scope of pharmacists to prescribe short-acting HCs. House Bill (HB) 2879 allows pharmacists to directly prescribe HC including the patch and pill, without a medical prescription. Women over 18 years of age can either initiate or continue HCs with a pharmacist, and women under 18 can continue a prescription.

This prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist, aims to determine contraceptive continuation and incident pregnancy rates between women receiving hormonal contraception from a pharmacist versus other prescriber. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates.

Connect with a study center

  • Oregon Health & Science University

    Portland, Oregon 97239
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.